Myriad Genetics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-0.4% -$800K
$210M
Cost of Revenue↑+5.5% +$3M
$63M
Gross Profit↓-2.7% -$4M
$147M
R&D↓-20.8% -$7M
$26M
SG&A
$139M
D&A↓-14.9% -$2M
$13M
Operating Income↓-16.5% -$3M
$-23M
EBITDA↓-14.9% -$2M
$13M
Interest Expense↑+528.6% +$4M
$4M
Interest Income↑+166.7% +$500K
$800K
Other Income/Expense↑+150.0% +$1M
$400K
Pretax Income↓-23.6% -$5M
$-26M
Tax Provision↑+33.3% +$300K
$1M
Net Income↓-24.0% -$5M
$-27M
Gross Margin↓-1.7pts
70.0%
Operating Margin↓-2.0pts
-11.3%
Net Margin↓-3.0pts
-13.3%
Effective Tax Rate↓-0.3pts
-4.6%
Deferred Tax Liabilities
—
ETR (Continuing Operations)↑+10.5pts
7.4%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-2.0pts
-0.1%
ETR Foreign Differential (pp)↑+2.7pts
0.0%
Revenue YoY Variation↓-7.5pts
-0.4%
Income YoY Variation↓-83.2pts
-16.5%
Revenue QoQ Variation↑+3.3pts
2.0%
Income QoQ Variation↑+47.7pts
92.9%